Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors

BACKGROUND/AIMS: Sirolimus (SRL) is a promising immunosuppressant replacingcalcineurin inhibitors (CNIs). This study was performed to evaluate the safetyand immunologic benefits of conversion to SRL in stable kidney transplant (KT)recipients exposed to CNIs for long periods. METHODS: Fourteen CNI-tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ji Hyun, Kim, Kyoung Woon, Kim, Bo-Mi, Chung, Byung Ha, Cho, Mi-La, Choi, Bum Soon, Park, Cheol Whee, Kim, Yong-Soo, Yang, Chul Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855095/
https://www.ncbi.nlm.nih.gov/pubmed/26968190
http://dx.doi.org/10.3904/kjim.2014.366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855095/
https://www.ncbi.nlm.nih.gov/pubmed/26968190
http://dx.doi.org/10.3904/kjim.2014.366

Ejemplares similares